Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuya Pal

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Journal of Genetic Counseling|October 18, 2014
Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?Deborah Cragun, Rita D DeBate, Tuya Pal
Expert Review of Molecular Diagnostics|August 29, 2020
Strategies to enhance identification of hereditary breast cancer gene carriersSonya Reid, Lucy B Spalluto, Tuya Pal
Genetic Testing and Molecular Biomarkers|January 25, 2019
Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination ActDeborah Cragun, Anne Weidner, Joy Kechik, et al.
Annals of Surgical Oncology|October 28, 2017
Comment on "Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey"Deborah Cragun, Susan Vadaparampil, Courtney Scherr, et al.
Journal of Genetic Counseling|December 6, 2013
Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionalsCristi Radford, Anya Prince, Karen Lewis, et al.
Cancer|June 11, 2008
A review of the clinical relevance of mismatch-repair deficiency in ovarian cancerTuya Pal, Jenny Permuth-Wey, Thomas A Sellers
Healthcare (Basel, Switzerland)|July 16, 2016
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineDeborah Cragun, Courtney Lewis, Lucia Camperlengo, et al.
Genes|July 27, 2024
Comparing Cancer Risk Management between Females with Truncating <i>CHEK2</i> 1100delC versus Missense <i>CHEK2</i> I157T VariantsDiego Garmendia, Anne Weidner, Lindsay Venton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
BRCA1 and BRCA2 mutations in a study of African American breast cancer patientsTuya Pal, Jenny Permuth-Wey, Tricia Holtje, et al.
Fertility and Sterility|February 10, 2009
Fertility in women with BRCA mutations: a case-control studyTuya Pal, David Keefe, Ping Sun, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Journal of Genetic Counseling|October 18, 2014
Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?Deborah Cragun, Rita D DeBate, Tuya Pal
Expert Review of Molecular Diagnostics|August 29, 2020
Strategies to enhance identification of hereditary breast cancer gene carriersSonya Reid, Lucy B Spalluto, Tuya Pal
Genetic Testing and Molecular Biomarkers|January 25, 2019
Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination ActDeborah Cragun, Anne Weidner, Joy Kechik, et al.
Annals of Surgical Oncology|October 28, 2017
Comment on "Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey"Deborah Cragun, Susan Vadaparampil, Courtney Scherr, et al.
Journal of Genetic Counseling|December 6, 2013
Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionalsCristi Radford, Anya Prince, Karen Lewis, et al.
Cancer|June 11, 2008
A review of the clinical relevance of mismatch-repair deficiency in ovarian cancerTuya Pal, Jenny Permuth-Wey, Thomas A Sellers
Healthcare (Basel, Switzerland)|July 16, 2016
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineDeborah Cragun, Courtney Lewis, Lucia Camperlengo, et al.
Genes|July 27, 2024
Comparing Cancer Risk Management between Females with Truncating <i>CHEK2</i> 1100delC versus Missense <i>CHEK2</i> I157T VariantsDiego Garmendia, Anne Weidner, Lindsay Venton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
BRCA1 and BRCA2 mutations in a study of African American breast cancer patientsTuya Pal, Jenny Permuth-Wey, Tricia Holtje, et al.
Fertility and Sterility|February 10, 2009
Fertility in women with BRCA mutations: a case-control studyTuya Pal, David Keefe, Ping Sun, et al.
Pageof 18